Skip to main content

Susan G. Kozauer, M.D.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Susan G. Kozauer, M.D.

Lb Pharmaceuticals Inc reported in an 8-K filed September 15, 2026 that Susan G. Kozauer, M.D. was appointed Chief Medical Officer, effective September 14, 2026.

“On September 15, 2026, LB Pharmaceuticals Inc (the "Company") announced that Susan G. Kozauer, M.D. has been appointed to serve as the Company's Chief Medical Officer, effective as of September 14, 2026 (the "Start Date").”
Lb Pharmaceuticals Inc Form 8-K, filed September 15, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Lb Pharmaceuticals Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.